Additional information
Yellow Powder
NA
ACI-020811
287.3-288.4°C
C11H13Cl2N5O2
318.16
Ambient
2-8°C
ocular hypertension
Pharmaceutical Impurity Standards
6-(2-imidazoline-2-ylidineamino)- 1,2,3,4-tetrahydroquinoxalin-2,3-dione dihydrochloride
6-(2-imidazoline-2-ylidineamino)- 1,2,3,4-tetrahydroquinoxalin-2,3-dione dihydrochloride
6-[(4,5-dihydro-1H-imidazol-2-yl)amino]-1,4-dihydro-2,3-quinoxalinedione





![TOFACITINIB DIMER (25 mg) (1,3-Bis{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-1,3-propanedione)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)